glp 1 ra injection New Guidelines on GLP-1 Drugs for Obesity Released Beyond the GLP-1RA weight loss

Appropriate intervention by the diabetes care team can improve inpatient glycemic control, reduce the incidence of hypoglycemia, enhance treatment outcomes, and lower the risk of diabetes-related complications

Gallbladder problems: GLP-1s may increase the risk of gallstones or other gallbladder issues

Gut microbiota and osteoarthritis management: an expert consensus of the European society for clinical and economic aspects of osteoporosis, osteoarthritis and musculoskeletal diseases (ESCEO)

Rather than binding to a single receptor like most drugs, this peptide influences numerous biological pathways simultaneously